Large-scale testing (Phase 3)Study completedNCT01028053
What this trial is testing
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
GE Healthcare 365